The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(4-benzhydrylpiperazin-1-yl)-N,N-diphenylacetamide ID: ALA599408
Cas Number: 866562-65-4
PubChem CID: 4229612
Max Phase: Preclinical
Molecular Formula: C31H31N3O
Molecular Weight: 461.61
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C(CN1CCN(C(c2ccccc2)c2ccccc2)CC1)N(c1ccccc1)c1ccccc1
Standard InChI: InChI=1S/C31H31N3O/c35-30(34(28-17-9-3-10-18-28)29-19-11-4-12-20-29)25-32-21-23-33(24-22-32)31(26-13-5-1-6-14-26)27-15-7-2-8-16-27/h1-20,31H,21-25H2
Standard InChI Key: QXNYWQVYZYCACA-UHFFFAOYSA-N
Molfile:
RDKit 2D
35 39 0 0 0 0 0 0 0 0999 V2000
16.8998 0.6803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7254 0.6803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1338 1.3877 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.7254 2.1037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8998 2.1037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4828 1.3877 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.6573 1.3865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2456 2.1015 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2476 0.6747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6582 2.8151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2472 3.5295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4208 3.5288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0071 2.8077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4246 2.0963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4225 0.6750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0087 -0.0402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4247 -0.7560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2544 -0.7523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6603 -0.0364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9593 1.3865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3730 0.6747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1986 0.6735 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.6083 -0.0425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6102 1.3842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4356 1.3785 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8513 2.0926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4374 2.8096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6077 2.8080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1998 2.0934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1943 -0.7561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6033 -1.4717 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4296 -1.4732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8453 -0.7533 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4298 -0.0407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9573 -0.0402 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16 17 2 0
1 6 1 0
17 18 1 0
7 9 1 0
18 19 2 0
19 9 1 0
2 3 1 0
3 20 1 0
8 10 2 0
20 21 1 0
3 4 1 0
21 22 1 0
10 11 1 0
22 23 1 0
4 5 1 0
22 24 1 0
11 12 2 0
24 25 2 0
5 6 1 0
25 26 1 0
12 13 1 0
26 27 2 0
27 28 1 0
13 14 2 0
28 29 2 0
29 24 1 0
14 8 1 0
23 30 2 0
6 7 1 0
30 31 1 0
9 15 2 0
31 32 2 0
1 2 1 0
32 33 1 0
15 16 1 0
33 34 2 0
34 23 1 0
7 8 1 0
21 35 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 461.61Molecular Weight (Monoisotopic): 461.2467AlogP: 5.76#Rotatable Bonds: 7Polar Surface Area: 26.79Molecular Species: NEUTRALHBA: 3HBD: ┄#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 7.46CX LogP: 5.98CX LogD: 5.65Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.35Np Likeness Score: -1.12
References 1. Pajouhesh H, Feng ZP, Ding Y, Zhang L, Pajouhesh H, Morrison JL, Belardetti F, Tringham E, Simonson E, Vanderah TW, Porreca F, Zamponi GW, Mitscher LA, Snutch TP.. (2010) Structure-activity relationships of diphenylpiperazine N-type calcium channel inhibitors., 20 (4): [PMID:20117000 ] [10.1016/j.bmcl.2010.01.008 ] 2. Zamponi GW, Feng ZP, Zhang L, Pajouhesh H, Ding Y, Belardetti F, Pajouhesh H, Dolphin D, Mitscher LA, Snutch TP.. (2009) Scaffold-based design and synthesis of potent N-type calcium channel blockers., 19 (22): [PMID:19815411 ] [10.1016/j.bmcl.2009.09.008 ]